| Catelog# |
Product |
CAS# |
Formula |
Purity(%) |
Inquiry |
First Page Previous Page [2704] [2705] [2706] 2707 [2708] [2709] [2710] [2711] Next Page Last Page Total 77002 items, Total 3081 Page Goto
| 2A-1177304 |
FENHEXAMID |
126833-17-8 |
|
0% |
Inquiry |
| 2A-1177305 |
DIMOXYSTROBIN PESTANAL |
149961-52-4 |
|
0% |
Inquiry |
| 2A-1177306 |
Orysastrobin |
248593-16-0 |
|
0% |
Inquiry |
| 2A-1177307 |
DIFLUMETORIM |
130339-07-0 |
|
0% |
Inquiry |
| 2A-1177308 |
Isotianil |
224049-04-1 |
|
0% |
Inquiry |
| 2A-1177309 |
Penthiopyrad |
183675-82-3 |
|
0% |
Inquiry |
| 2A-1177310 |
Fluopyram |
658066-35-4 |
|
0% |
Inquiry |
| 2A-1177311 |
Isotianil |
224049-04-1 |
|
0% |
Inquiry |
| 2A-1177312 |
Metaflumizone |
139968-49-3 |
|
0% |
Inquiry |
| 2A-1177313 |
Cyantraniliprole |
736994-63-1 |
|
0% |
Inquiry |
| 2A-1177314 |
Fluensulfone |
318290-98-1 |
|
0% |
Inquiry |
| 2A-1177315 |
(E)-Methyl-2-(2-broMoMethylphenyl)-2-MethoxyiMinoacetate |
133409-72-0 |
|
0% |
Inquiry |
| 2A-1177316 |
prothioconazole-desthio |
120983-64-4 |
|
0% |
Inquiry |
| 2A-1177317 |
N/A |
193741-67-2 |
|
0% |
Inquiry |
| 2A-1177318 |
IN-QCC64 (5B intermediate) |
117428-95-2 |
|
0% |
Inquiry |
| 2A-1177319 |
3-(2,4,6-TRIMETHYLPHENYLSULFONYL)-1,2,4-TRIAZOLE |
149591-20-8 |
|
0% |
Inquiry |
| 2A-1177322 |
5-METHYL-3-HEPTANONE |
541-85-5 |
|
0% |
Inquiry |
| 2A-1177702 |
15-ACETOXY-3ALPHA,4BETA-DIHYDROXY-12,13-EPOXYTRICHOTHEC-9-ENE |
2623-22-5 |
|
0% |
Inquiry |
| 2A-1177702 |
15-ACETOXY-3ALPHA,4BETA-DIHYDROXY-12,13-EPOXYTRICHOTHEC-9-ENE |
2623-22-5 |
|
0% |
Inquiry |
| 2A-1177703 |
AFLATOXICOL I NATURAL ISOMER*VACUUM DRIE D |
29611-03-8 |
|
0% |
Inquiry |
| 2A-1177704 |
(2R,3R,4aR)-2,3,4,4a-Tetrahydro-2,3,7-trihydroxy-9-Methoxy-4a-Methyl-6H-dibenzo[b,d]pyran-6-one |
889101-41-1 |
|
0% |
Inquiry |
| 2A-1177705 |
BETA-ZEARALANOL |
42422-68-4 |
|
0% |
Inquiry |
| 2A-1177706 |
CHAETOCIN FROM CHAETOMIUM MINUTUM |
28097-03-2 |
|
0% |
Inquiry |
| 2A-1177707 |
CHAETOGLOBOSIN A |
50335-03-0 |
|
0% |
Inquiry |
| 2A-1177708 |
citreoviridin |
25425-12-1 |
|
0% |
Inquiry |
| |
|
|
|
